Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers

Clin Chim Acta. 2010 Aug 5;411(15-16):1034-40. doi: 10.1016/j.cca.2010.03.033. Epub 2010 Mar 30.

Abstract

Background: The receptor for advanced glycation end-products (RAGEs) and its gene polymorphisms are implicated in the pathogenesis of different chronic diseases including diabetes and its complications. Infant formulas contain high amounts of advanced glycation end-products (AGEs) - the ligands of RAGE.

Methods: In this cross-sectional study, we examined the impact of G82S and -374 A/T polymorphisms in the gene encoding RAGE on standard blood chemistry, soluble (s)RAGE and inflammatory markers in 244 healthy infants (3-16months of age) and in 119 healthy mothers. Children were subdivided according to age (younger and older than 8months) and for the -374 A/T polymorphism according to the feeding regimen (breast-fed vs. infant formula-fed).

Results: Minor allele of the RAGE gene polymorphism G82S was associated with reduced plasma sRAGE in all age groups and with increased sICAM-1 in older children and mothers. Minor allele carrying mothers had decreased insulin sensitivity and HDL. The A allele of the RAGE gene promoter polymorphism -374 A/T was associated with higher indices of insulin resistance in young infant formula-fed, but not breast-fed children. In older, formerly infant formula-fed children signs of insulin resistance diminished, while formerly breast-fed children with A allele were more insulin sensitive.

Conclusions: The phenotype of minor allele carriers in G82S is associated with reduced levels of protective sRAGE in healthy infants. With increasing age sICAM-1 levels increased and insulin resistance developed. In early childhood the phenotype of the -374 A/T polymorphism was diet-dependently associated with changes in glucose metabolism, which diminished with increasing age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / metabolism
  • Diet
  • Female
  • Glycation End Products, Advanced / blood
  • Health*
  • Humans
  • Infant
  • Infant Formula
  • Inflammation / blood
  • Inflammation / metabolism
  • Male
  • Milk, Human
  • Mothers*
  • Phenotype
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic / genetics
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / genetics*

Substances

  • Blood Glucose
  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic